(Q24246433)

3

0 references

author name string

Smruta Shanbhag

1

0 references

Lorna Aucott

2

0 references

Mark A Hamilton

4

0 references

Alison R McTavish

Cochrane Database of Systematic Reviews

5

0 references

publication date

24 January 2007

0 references

published in

0 references

cites work

Growth hormone for in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Depot versus daily administration of gonadotrophin releasing hormone agonist protocols for pituitary desensitization in assisted reproduction cycles

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Comparison of ovarian stimulation regimens for in vitro fertilization (IVE) with and without a gonadotropin-releasing hormone (GnRH) agonist: results of a randomized study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

A randomized prospective study on the effect of short and long Buserelin treatment in women with repeated unsuccessful in vitro fertilization (IVF) cycles due to inadequate ovarian response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilization: a prospective, randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

A controlled trial of natural cycle versus microdose gonadotropin-releasing hormone analog flare cycles in poor responders undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Short versus long gonadotropin-releasing hormone analogue suppression protocols for superovulation in patients > or = 40 years old undergoing intracytoplasmic sperm injection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

A comparative study of high fixed-dose and decremental-dose regimens of gonadotropins in a minidose gonadotropin-releasing hormone agonist flare protocol for poor responders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization–embryo transfer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Minidose gonadotropin-releasing hormone agonist is the treatment of choice in poor responders with high follicle-stimulating hormone levels.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Recruitment of follicles by recombinant human follicle-stimulating hormone commencing in the luteal phase of the ovarian cycle

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Cessation of gonadotropin-releasing hormone analogue (GnRH-a) upon down-regulation versus conventional long GnRH-a protocol in poor responders undergoing in vitro fertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Increasing the gonadotrophin dose in the course of an in vitro fertilization cycle does not rectify an initial poor response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

GnRH antagonist in IVF poor-responder patients: results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Evaluation and treatment of low responders in assisted reproductive technology: a challenge to meet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Cessation of low-dose gonadotropin releasing hormone agonist therapy followed by high-dose gonadotropin stimulation yields a favorable ovarian response in poor responders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Effect of gonadotropin-releasing hormone agonist and antagonist on steroidogenesis of low responders undergoingin vitrofertilization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Poor responders to ovulation induction: is proceeding to in-vitro fertilization worthwhile?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Recombinant follicle stimulating hormone stimulation in poor responders with normal basal concentrations of follicle stimulating hormone and oestradiol: improved reproductive outcome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Adjuvant L-arginine treatment for in-vitro fertilization in poor responder patients.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Addition of GnRH antagonist in cycles of poor responders undergoing IVF.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

High doses of gonadotrophins combined with stop versus non-stop protocol of GnRH analogue administration in low responder IVF patients: a prospective, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Recombinant follicle stimulating hormone is effective in poor responders to highly purified follicle stimulating hormone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Rescue of IVF cycles by HMG in pituitary down-regulated normogonadotrophic young women characterized by a poor initial response to recombinant FSH.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized cont

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Expected poor responders on the basis of an antral follicle count do not benefit from a higher starting dose of gonadotrophins in IVF treatment: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Effects of transdermal testosterone application on the ovarian response to FSH in poor responders undergoing assisted reproduction technique--a prospective, randomized, double-blind study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Pretreatment with transdermal testosterone may improve ovarian response to gonadotrophins in poor-responder IVF patients with normal basal concentrations of FSH.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Physiology: A mathematical model of follicle dynamics in the human ovary

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Assisted conception following poor ovarian response to gonadotrophin stimulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Pituitary Control of Ovarian Function — Concepts Derived from Gonadotrophin Therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004379.PUB2

7 January 2021

Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD003973

Identifiers

DOI

10.1002/14651858.CD004379.PUB2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2950845

OpenCitations bibliographic resource ID

2950845

1 reference